Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India. IPC is created to set standards of drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region. It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-centre dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; surgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries.
A randomized, open-Iabel, controlled clinical trial to decipher the role of chrono pharmacokinetics and chrono genomics of tyrosine kinase inhibitors in the treatment of non-small cell lung cancer patients.
A need was felt to establish a nationally cohesive, interdisciplinary Ph.D. programme in biosciences to expand the scale of generating highly skilled, globally competitive human resource. It was envisioned that the trained human resource produced through this programme would be better equipped to provide bioscience-based pioneering solutions to contemporary problems relevant nationally and globally.
Bharat Parenterals Ltd. is a Gujarat based pharmaceutical company, established in 1992 by Mr. Ramesh Desai, who started the company with a vision of making world class affordable medicines and to take it to the forefront of contract manufacturing units in Gujarat.